Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
2014 · Molecular Oncology · 159 citations
https://doi.org/10.1016/j.molonc.2014.09.003
E
Erik Laurini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
235
Papers
4.2K
Citations
37
h-index
113
i10-index
Erik Laurini is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Dendrimers and Hyperbranched Polymers & Pharmacological Receptor Mechanisms and Effects & RNA Interference and Gene Delivery. The author has an h-index of 37, co-authored 200 publications.
ORCID: 0000-0001-6092-6532Papers by this author
worksMolecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies
2021 · Scientific Reports · 52 citations
https://doi.org/10.1038/s41598-021-99827-3
β‐Catenin in desmoid‐type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression
2017 · Molecular Oncology · 39 citations
https://doi.org/10.1002/1878-0261.12101
Mixed-monolayer functionalized gold nanoparticles for cancer treatment: Atomistic molecular dynamics simulations study
2021 · Biosystems · 19 citations
https://doi.org/10.1016/j.biosystems.2021.104354
Multimodel approach for accurate determination of industry-driven properties for Polymer Nanocomposite Materials
2018 · Journal of Computational Science · 10 citations
https://doi.org/10.1016/j.jocs.2018.03.002
Molecular insights into the binding of human serum albumin to charged dendritic nanomicelles: A synergistic experimental and in silico approach
2025 · Journal of Molecular Liquids · 0 citations
https://doi.org/10.1016/j.molliq.2025.128770
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat